Hangzhou AGS MedTech Co. Ltd.SSE: 688581

Announcement on Convening the Q3 2025 Performance Briefing

Dec 9, 2025 · Issued by Hangzhou AGS MedTech Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Dec 9, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-1007

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Hangzhou AGS MedTech Co. Ltd. on 6ix

Earlier from Hangzhou AGS MedTech

Report for Q3 2025Oct 28, 2025
Announcement on Expiration of Shareholder's Shareholding Reduction Plan and Results of Shareholding ReductionOct 24, 2025
Announcement on Vesting Results of the 2nd Vesting Period of Those Initially Granted and the 1st Vesting Period of Those Reserved for Grant in 2023 Restricted Stock Incentive Plan and Listing of SharesOct 11, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Sep 27, 2025
Announcement on Result of Shareholding Reduction by ShareholderSep 12, 2025

Later from Hangzhou AGS MedTech

Announcement on Voluntary Disclosure of Obtaining Medical Device Registration CertificateDec 25, 2025
Announcement on Capital Increase to Holding Subsidiary and Related Party TransactionsJan 10
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jan 27
Announcement on Signing Quadripartite and Quintipartite Supervision Agreement for Deposit of Raised Fund in Special AccountFeb 27
Announcement on Using Partial Idle Self-owned Funds for Cash ManagementMar 12

All Hangzhou AGS MedTech news releases

Follow Hangzhou AGS MedTech into a list and get an email when it puts out news.

Follow Hangzhou AGS MedTech